Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2014, Article ID 193523, 9 pages
http://dx.doi.org/10.1155/2014/193523
Research Article

PELP1 Suppression Inhibits Colorectal Cancer through c-Src Downregulation

1Hubei Province Key Laboratory on Cardiovascular, Cerebrovascular, and Metabolic Disorders, Hubei University of Science and Technology, Xianning 437100, China
2The Basic Medical School, Hubei University of Science and Technology, Xianning 437100, China
3School of Pharmacy, Hubei University of Science and Technology, Xianning 437100, China
4Wuhan Blood Center, Wuhan 430030, China

Received 13 February 2014; Accepted 20 April 2014; Published 22 May 2014

Academic Editor: Xiaoqian Chen

Copyright © 2014 Zhifeng Ning et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. Gansler, P. A. Ganz, M. Grant et al., “Sixty years of ca: A cancer journal for clinicians,” CA Cancer Journal for Clinicians, vol. 60, no. 6, pp. 345–350, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Jemal, R. Siegel, J. Xu, and E. Ward, “Cancer statistics, 2010,” CA Cancer Journal for Clinicians, vol. 60, no. 5, pp. 277–300, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. J. B. O'Connell, M. A. Maggard, and C. Y. Ko, “Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging,” Journal of the National Cancer Institute, vol. 96, no. 19, pp. 1420–1425, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Narayan and D. Roy, “Role of APC and DNA mismatch repair genes in the development of colorectal cancers,” Molecular Cancer, vol. 2, article 41, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. D. M. Lonard and B. W. O'Malley, “Nuclear receptor coregulators: judges, juries, and executioners of cellular regulation,” Molecular Cell, vol. 27, no. 5, pp. 691–700, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Rudolph, C. Toth, M. Hoffmeister et al., “Expression of oestrogen receptor beta and prognosis of colorectal cancer,” British Journal of Cancer, vol. 107, pp. 831–839, 2012. View at Google Scholar
  7. Y. Q. He, J. Q. Sheng, X. L. Ling et al., “Estradiol regulates miR-135b and mismatch repair gene expressions via estrogen receptor-β in colorectal cells,” Experimental & Molecular Medicine, vol. 44, pp. 723–732, 2012. View at Google Scholar
  8. D. Saleiro, G. Murillo, R. V. Benya, M. Bissonnette, J. Hart, and R. G. Mehta, “Estrogen receptor-beta protects against colitis-associated neoplasia in mice,” International Journal of Cancer, vol. 131, pp. 2553–2561, 2012. View at Google Scholar
  9. R. M. Hasson, A. Briggs, A. M. Carothers et al., “Estrogen receptor α or β loss in the colon of Min/+ mice promotes crypt expansion and impairs TGFβ and HNF3β signaling,” Carcinogenesis, vol. 35, no. 1, pp. 96–102, 2014. View at Publisher · View at Google Scholar
  10. P. D. Grivas, V. Tzelepi, G. Sotiropoulou-Bonikou, Z. Kefalopoulou, A. G. Papavassiliou, and H. Kalofonos, “Estrogen receptor α/β, AIB1, and TIF2 in colorectal carcinogenesis: do coregulators have prognostic significance?” International Journal of Colorectal Disease, vol. 24, no. 6, pp. 613–622, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Jubb, S. Bell, and P. Quirke, “Methylation and colorectal cancer,” The Journal of Pathology, vol. 195, pp. 111–134, 2001. View at Google Scholar
  12. Y. Kondo and J. P. J. Issa, “Epigenetic changes in colorectal cancer,” Cancer and Metastasis Reviews, vol. 23, no. 1-2, pp. 29–39, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. J.-P. J. Issa, Y. L. Ottaviano, P. Celano, S. R. Hamilton, N. E. Davidson, and S. B. Baylin, “Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon,” Nature Genetics, vol. 7, no. 4, pp. 536–540, 1994. View at Publisher · View at Google Scholar · View at Scopus
  14. F. Al-Azzawi and M. Wahab, “Estrogen and colon cancer: current issues,” Climacteric, vol. 5, no. 1, pp. 3–14, 2002. View at Google Scholar · View at Scopus
  15. J. Wang, S. Song, L. Shi et al., “Temporal expression of pelp1 during proliferation and osteogenic differentiation of rat bone marrow mesenchymal stem cells,” PLoS ONE, vol. 8, Article ID 0075477, 2013. View at Google Scholar
  16. Y. Yan, W. Zeng, S. Song et al., “Vitamin C induces periodontal ligament progenitor cell differentiation via activation of ERK pathway mediated by PELP1,” Protein Cell, vol. 4, pp. 620–627, 2013. View at Google Scholar
  17. J. Wang, Q. Zhu, S. Song et al., “Increased PELP1 expression in rat periodontal ligament tissue in response to estrogens treatment,” Journal of Molecular Histology, vol. 44, pp. 347–356, 2013. View at Google Scholar
  18. B. J. Girard, A. R. Daniel, C. A. Lange, and J. H. Ostrander, “PELP1: a review of PELP1 interactions, signaling, and biology,” Molecular and Cellular Endocrinology, vol. 8, pp. 00326–00322, 2013. View at Google Scholar
  19. I. M. Bennani-Baiti, “Integration of ERalpha-PELP1-HER2 signaling by LSD1 (KDM1A/AOF2) offers combinatorial therapeutic opportunities to circumventing hormone resistance in breast cancer,” Breast Cancer Research, vol. 14, article 112, 2012. View at Google Scholar
  20. V. Cortez, M. Mann, S. Tekmal et al., “Targeting the PELP1-KDM1 axis as a potential therapeutic strategy for breast cancer,” Breast Cancer Research, vol. 14, article R108, 2012. View at Publisher · View at Google Scholar
  21. S. Aust, P. Horak, D. Pils et al., “The prognostic value of estrogen receptor beta and proline-, glutamic acid- and leucine-rich protein 1 (PELP1) expression in ovarian cancer,” BMC Cancer, vol. 13, pp. 1471–2407, 2013. View at Google Scholar
  22. J. Wan and X. Li, “PELP1/MNAR suppression inhibits proliferation and metastasis of endometrial carcinoma cells,” Oncology Reports, vol. 28, pp. 2035–2042, 2012. View at Google Scholar
  23. R. K. Vadlamudi, S. Balasenthil, R. R. Broaddus, J.-Å. Gustafsson, and R. Kumar, “Deregulation of estrogen receptor coactivator proline-, glutamic acid-, and leucine-rich protein-1/modulator of nongenomic activity of estrogen receptor in human endometrial tumors,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 12, pp. 6130–6138, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. P. Ravindranathan, T. K. Lee, L. Yang et al., “Peptidomimetic targeting of critical androgen receptor-coregulator interactions in prostate cancer,” Nature Communications, vol. 4, article 1923, 2013. View at Publisher · View at Google Scholar
  25. Z. Kefalopoulou, V. Tzelepi, V. Zolota et al., “Prognostic value of novel biomarkers in astrocytic brain tumors: nuclear receptor co-regulators AIB1, TIF2, and PELP1 are associated with high tumor grade and worse patient prognosis,” Journal of Neuro-Oncology, vol. 106, no. 1, pp. 23–31, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. D. C. Márquez-Garbán, H. W. Chen, M. C. Fishbein, L. Goodglick, and R. J. Pietras, “Estrogen receptor signaling pathways in human non-small cell lung cancer,” Steroids, vol. 72, no. 2, pp. 135–143, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. V. Tzelepi, P. Grivas, Z. Kefalopoulou, H. Kalofonos, J. N. Varakis, and G. Sotiropoulou-Bonikou, “Expression of estrogen receptor co-regulators NCoR and PELP1 in epithelial cells and myofibroblasts of colorectal carcinomas: cytoplasmic translocation of NCoR in epithelial cells correlates with worse prognosis,” Virchows Archiv, vol. 454, no. 1, pp. 41–53, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. P. D. Grivas, V. Tzelepi, G. Sotiropoulou-Bonikou, Z. Kefalopoulou, A. G. Papavassiliou, and H. Kalofonos, “Expression of ERa,ERß and co-regulator PELP1/MNAR in colorectal cancer: prognostic significance and clinicopathologic correlations,” Cellular Oncology, vol. 31, no. 3, pp. 235–247, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. J. K. Lee, D. M. Havaleshko, H. Cho et al., “A strategy for predicting the chemosensitivity of human cancers and its application to drug discovery,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 32, pp. 13086–13091, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. U. T. Shankavaram, W. C. Reinhold, S. Nishizuka et al., “Transcript and protein expression profiles of the NCI-60 cancer cell panel: an integromic microarray study,” Molecular Cancer Therapeutics, vol. 6, no. 3, pp. 820–832, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. M. J. Garnett, E. J. Edelman, S. J. Heidorn et al., “Systematic identification of genomic markers of drug sensitivity in cancer cells,” Nature, vol. 483, no. 7391, pp. 570–575, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. H. Dong, H. Guo, L. Xie et al., “The metastasis-associated gene MTA3, a component of the Mi-2/NuRD transcriptional repression complex, predicts prognosis of gastroesophageal junction adenocarcinoma,” PLoS ONE, vol. 8, Article ID e62986, 2013. View at Google Scholar
  33. A. Barzi, A. M. Lenz, M. J. Labonte, and H. J. Lenz, “Molecular pathways: estrogen pathway in colorectal cancer,” Clinical Cancer Research, vol. 19, pp. 5842–5848, 2013. View at Google Scholar
  34. M. N. Passarelli, A. I. Phipps, J. D. Potter et al., “Common single-nucleotide polymorphisms in the estrogen receptor beta promoter are associated with colorectal cancer survival in postmenopausal women,” Cancer Research, vol. 73, pp. 767–775, 2013. View at Google Scholar
  35. M. L. Slattery, C. Sweeney, M. Murtaugh et al., “Associations between vitamin D, vitamin D receptor gene and the androgen receptor gene with colon and rectal cancer,” International Journal of Cancer, vol. 118, no. 12, pp. 3140–3146, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. M. Mariani, G. F. Zannoni, S. Sioletic et al., “Gender influences the class III and V beta-tubulin ability to predict poor outcome in colorectal cancer,” Clinical Cancer Research, vol. 18, pp. 2964–2975, 2012. View at Google Scholar
  37. R. K. Vadlamudi and R. Kumar, “Functional and biological properties of the nuclear receptor coregulator PELP1/MNAR,” Nuclear receptor signaling, vol. 5, article e004, 2007. View at Google Scholar · View at Scopus
  38. M. GS, “The hunting of the Src,” Nature Reviews Molecular Cell Biology, vol. 2, pp. 467–475, 2001. View at Google Scholar
  39. S. Zhang and D. Yu, “Targeting Src family kinases in anti-cancer therapies: turning promise into triumph,” Trends in Pharmacological Sciences, vol. 33, no. 3, pp. 122–128, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. D. Chakravarty, S. S. Nair, B. Santhamma et al., “Extranuclear functions of ER impact invasive migration and metastasis by breast cancer cells,” Cancer Research, vol. 70, no. 10, pp. 4092–4101, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. C. Dimple, S. S. Nair, R. Rajhans et al., “Role of PELP1/MNAR signaling in ovarian tumorigenesis,” Cancer Research, vol. 68, no. 12, pp. 4902–4909, 2008. View at Publisher · View at Google Scholar · View at Scopus
  42. R. Rajhans, H. B. Nair, S. S. Nair et al., “Modulation of in situ estrogen synthesis by proline-, glutamic acid-, and leucine-rich protein-1: potential estrogen receptor autocrine signaling loop in breast cancer cells,” Molecular Endocrinology, vol. 22, no. 3, pp. 649–664, 2008. View at Publisher · View at Google Scholar · View at Scopus
  43. B. J. Cheskis, J. Greger, N. Cooch et al., “MNAR plays an important role in ERa activation of Src/MAPK and PI3K/Akt signaling pathways,” Steroids, vol. 73, no. 9-10, pp. 901–905, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. M. Kayahara, J. Ohanian, V. Ohanian, A. Berry, R. Vadlamudi, and D. W. Ray, “MNAR functionally interacts with both NH2- and COOH-terminal GR domains to modulate transactivation,” The American Journal of Physiology—Endocrinology and Metabolism, vol. 295, no. 5, pp. E1047–E1055, 2008. View at Publisher · View at Google Scholar · View at Scopus